144 related articles for article (PubMed ID: 21315211)
1. Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE).
Edwards J; Goodman SG; Yan RT; Welsh RC; Kornder JM; Deyoung JP; Chauret D; Picard JP; Eagle KA; Yan AT
Am Heart J; 2011 Feb; 161(2):291-7. PubMed ID: 21315211
[TBL] [Abstract][Full Text] [Related]
2. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
Rao RV; Goodman SG; Yan RT; Spencer FA; Fox KA; DeYoung JP; Rose B; Grondin FR; Gallo R; Gore JM; Yan AT;
Am Heart J; 2009 Apr; 157(4):642-50.e1. PubMed ID: 19332190
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of clopidogrel in acute coronary syndrome.
Zambahari R; Kwok OH; Javier S; Mak KH; Piyamitr S; Tri Ho HQ; Hwang JJ; Suryawan R; Chow WH
Int J Clin Pract; 2007 Mar; 61(3):473-81. PubMed ID: 17313616
[TBL] [Abstract][Full Text] [Related]
5. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
[TBL] [Abstract][Full Text] [Related]
6. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.
Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ
Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770
[TBL] [Abstract][Full Text] [Related]
8. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events.
Sibbald M; Yan AT; Huang W; Fox KA; Gore JM; Steg PG; Eagle KA; Brieger D; Montalescot G; Goodman SG
Am Heart J; 2010 Nov; 160(5):855-61. PubMed ID: 21095272
[TBL] [Abstract][Full Text] [Related]
9. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
10. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
11. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
Awad HH; Zubaid M; Alsheikh-Ali AA; Al Suwaidi J; Anderson FA; Gore JM; Goldberg RJ
Am J Cardiol; 2011 Nov; 108(9):1252-8. PubMed ID: 21880292
[TBL] [Abstract][Full Text] [Related]
12. [Optimisation of the myocardial infarction pharmacotherapy--important insights from the COMMIT Trial].
Drozdz J
Kardiol Pol; 2006 Feb; 64(2):230-1; discussion 232-3. PubMed ID: 16680853
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
Mariani M; Mariani G; De Servi S
Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
15. Novel antiplatelet strategies in acute coronary syndromes.
Sabatine MS
Cleve Clin J Med; 2009 Apr; 76 Suppl 1():S8-15. PubMed ID: 19332592
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel in the management of acute coronary syndromes: indications, results, obstacles.
Amsterdam EA
Crit Pathw Cardiol; 2009 Jun; 8(2):49-54. PubMed ID: 19491569
[TBL] [Abstract][Full Text] [Related]
17. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
19. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
[TBL] [Abstract][Full Text] [Related]
20. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.
Ho PM; Tsai TT; Wang TY; Shetterly SM; Clarke CL; Go AS; Sedrakyan A; Rumsfeld JS; Peterson ED; Magid DJ
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):303-8. PubMed ID: 20354221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
